Some mTOR inhibitors have shown inhibitory function on CSC (Francipane and Lagasse, 2016), for example, rapamycin, everolimus, and PF-04691502 can inhibit the activation of breast cancer stem cells induced by tamoxifen (Karthik et al., 2015). Here, MTOR is linked to breast cancer.